GlassScriptPhysician profile
Sarah E Moncado
NPI 1104103969
$728.41
in general payments reported to CMS, 2019-2025
8 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $89.77 · 2024: $347 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.82 |
| Education | $166.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $186.65 | 2023-2025 | Imfinzi, Calquence |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2025 | Reblozyl |
| Rigel Pharmaceuticals, INC. | $124.74 | 2024 | Tavalisse, Rezlidhia |
| Adaptive Biotechnologies Corporation | $99.20 | 2024 | Clonoseq |
| Abbvie INC. | $79.28 | 2024 | |
| Incyte Corporation | $71.53 | 2023-2024 | Jakafi, Pemazyre, Monjuvi |
| Alexion Pharmaceuticals, INC. | $22.29 | 2024 | Ultomiris |
| Janssen Biotech, INC. | $19.72 | 2023 | Darzalex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Moncado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.